Cargando…

APOC3 rs2070667 Associates with Serum Triglyceride Profile and Hepatic Inflammation in Nonalcoholic Fatty Liver Disease

Single-nucleotide polymorphisms (SNPs) of apolipoprotein C3 (APOC3) play important role in lipid metabolism, and dyslipidemia underlies nonalcoholic fatty liver disease (NAFLD). But the correlation of serum lipidomics, APOC3 SNPs, and NAFLD remains limited understood. Enrolling thirty-four biopsy-pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Qing-Yang, Li, Han, Cao, Hai-Xia, Pan, Qin, Fan, Jian-Gao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718051/ https://www.ncbi.nlm.nih.gov/pubmed/33294458 http://dx.doi.org/10.1155/2020/8869674

Ejemplares similares

PNPLA3 rs139051 is associated with phospholipid metabolite profile and hepatic inflammation in nonalcoholic fatty liver disease
por: Luo, Ji-Jun, et al.
Publicado: (2018)

APOC3: Triglycerides do matter
por: Hassan, Mohamed
Publicado: (2014)

PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease
por: Wang, Jin-Zhi, et al.
Publicado: (2018)

PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
por: Zhang, Rui-Nan, et al.
Publicado: (2021)

Dissociation Between APOC3 Variants, Hepatic Triglyceride Content and Insulin Resistance
por: Kozlitina, Julia, et al.
Publicado: (2011)

APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism
por: Giammanco, Antonina, et al.
Publicado: (2023)

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
por: Borén, Jan, et al.
Publicado: (2020)

Associations of the APOC3 rs5128 polymorphism with plasma APOC3 and lipid levels: a meta-analysis
por: Song, Yongyan, et al.
Publicado: (2015)

Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride lowering
por: Ramms, Bastian, et al.
Publicado: (2022)

A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
por: Timpson, Nicholas J., et al.
Publicado: (2014)

APOC3 genetic variation, serum triglycerides, and risk of coronary artery disease in Asian Indians, Europeans, and other ethnic groups
por: Goyal, Shiwali, et al.
Publicado: (2021)

Erratum: A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
por: Timpson, Nicholas J., et al.
Publicado: (2015)

Frequency and phenotype consequence of APOC3 rare variants in patients with very low triglyceride levels
por: Crawford, Dana C., et al.
Publicado: (2018)

N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels
por: Alexander, Veronica J, et al.
Publicado: (2019)

Increased Serum Levels of LIGHT/TNFSF14 in Nonalcoholic Fatty Liver Disease: Possible Role in Hepatic Inflammation
por: Otterdal, Kari, et al.
Publicado: (2015)

Association of Adiponectin rs1501299 and rs266729 Gene Polymorphisms With Nonalcoholic Fatty Liver Disease
por: Hashemi, Mohammad, et al.
Publicado: (2013)

Hepatic inflammation: an important target for biomarker development in nonalcoholic fatty liver disease
por: Khan, Hiba, et al.
Publicado: (2023)

The triglyceride and glucose index and risk of nonalcoholic fatty liver disease: A dose–response meta-analysis
por: Ling, Qin, et al.
Publicado: (2023)

Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease
por: Kim, Min Chul, et al.
Publicado: (2020)

Serum folate associated with nonalcoholic fatty liver disease and advanced hepatic fibrosis
por: Chen, Hao-Kai, et al.
Publicado: (2023)

Serum iron and risk of nonalcoholic fatty liver disease and advanced hepatic fibrosis in US adults
por: Yang, Huan-Huan, et al.
Publicado: (2021)

Saturated Fatty Acid Inhibits Viral Replication in Chronic Hepatitis B Virus Infection With Nonalcoholic Fatty Liver Disease by Toll-Like Receptor 4-Mediated Innate Immune Response
por: Zhang, Rui-Nan, et al.
Publicado: (2015)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Serum markers for predicting advanced fibrosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease
por: Wang, Qi, et al.
Publicado: (2021)

The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease
por: Zhang, Shujun, et al.
Publicado: (2017)

A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease
por: Zheng, Rongjiong, et al.
Publicado: (2018)

Triglyceride-Glucose Index is Significantly Associated with the Risk of Hyperuricemia in Patients with Nonalcoholic Fatty Liver Disease
por: Qi, Jiaxin, et al.
Publicado: (2023)

Hepatic Innervations and Nonalcoholic Fatty Liver Disease
por: Adori, Monika, et al.
Publicado: (2023)

Metabolic characterisation of disturbances in the APOC3/triglyceride-rich lipoprotein pathway through sample-based recall by genotype
por: Corbin, Laura J., et al.
Publicado: (2020)

Relation between triglycerides and the severity of acute pancreatitis combined with nonalcoholic fatty liver disease: a retrospective study
por: Zhu, Lei, et al.
Publicado: (2023)

A correlation study of the relationships between nonalcoholic fatty liver disease and serum triglyceride concentration after an oral fat tolerance test
por: Hou, Xiaoyu, et al.
Publicado: (2021)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
por: Niu, Shu, et al.
Publicado: (2023)

Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis
por: Tang, Shan, et al.
Publicado: (2020)

Validation of PAS Kinase, a Regulator of Hepatic Fatty Acid and Triglyceride Synthesis, as a Therapeutic Target for Nonalcoholic Steatohepatitis
por: Swiatek, Wojciech, et al.
Publicado: (2020)

Profile analysis and functional modeling identify circular RNAs in nonalcoholic fatty liver disease as regulators of hepatic lipid metabolism
por: Xie, Yang, et al.
Publicado: (2022)

Short hydrocarbon stapled ApoC2-mimetic peptides activate lipoprotein lipase and lower plasma triglycerides in mice
por: Sviridov, Denis, et al.
Publicado: (2023)

Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects
por: Zhang, Shujun, et al.
Publicado: (2017)

Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes
por: Carlier, Aurélie, et al.
Publicado: (2020)

Association between triglyceride–glucose index and nonalcoholic fatty liver disease in type 2 diabetes mellitus
por: Li, Wei, et al.
Publicado: (2022)

40 Years of the APOC Partnership
por: Roungou, Jean-Baptist, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pkm3ttipeb0t5fbrvg9hhkg7oi